periop conference working toward zero ssi - sep 11 2010
TRANSCRIPT
1
Working Toward Zero Infection Rate
Maureen Spencer, RN, M.Ed, CICInfection Control Manager
New England Baptist Hospital,Boston, Mass. 02120
617 754-5332 [email protected]
Disclosure: Ethicon and Cardinal Health Speaker’s Bureau
2
Topics:
• New England Baptist Hospital and Orthopedics• Multidisciplinary Team Work• Identifying Problems:
▫ OR Environment▫ Central Supply▫ Housekeeping▫ Hand Hygiene
• Action Plans: ▫ Innovative Technologies
• The Evidence: ▫ What Were The Outcomes
NEBH SSI Rates 2003 – 2010(outpatient and inpatient infections)
3
GENERAL SSI FY03 FY04 FY05 FY06 FY07 FY08 FY09 FY10(Oct-Jul)
# Infections 6 1 3 4 2 2 1 0# Procedures 1073 920 780 692 567 467 369Infection Rate 0.6 0.1 0.4 0.5 0.3 0.3 0.2 0
ORTHOPEDIC SSI# Infections 63 60 49 46 39 37 28 27# Procedures 8837 9669 9216 8986 9027 8884 8890 8256Overall Infection Rate 0.7 0.6 0.5 0.5 0.4 0.4 0.3 0.3#Hip Infections 14 5 4 7 5 5 10 8 Hip Prosthesis Rate 1.0 0.3 0.2 0.4 0.3 0.3 0.5 0.4#Knee Infections 21 14 11 7 7 11 9 7 Knee Prosthesis Rate 1.6 1.0 0.7 0.4 0.3 0.5 0.4 0.3#Laminectomy Infec. 6 9 7 7 12 4 0 3 Laminectomy Rate 0.7 0.9 0.6 0.8 1.3 0.5 0.0 0.6#Spinal Fusions Infec. 5 15 12 12 5 5 3 3 Spinal Fusion Rate 0.8 2.0 1.4 1.1 0.4 0.4 0.3 0.4
4
Orthopedic Surgical Site Infection
Orthopedic Total Joint Infections: Hip or Knee aspiration under
fluoroscopy If positive – irrigation and
debridement – liner exchange or Removal of hardware may be
necessary Insertion of antibiotic spacers Revisions at future date Long term IV antibiotics in
community or rehab Future worry about the joint In other words:
DEVASTATING FOR THE PATIENT AND THE SURGEON
5
2003 - Established a Multidisciplinary TeamThe team included representatives from • OR nursing, CSS• Orthopedic surgeons (Joint, Spine) & Anesthesia• Managers from infection control, healthcare quality,
facilities and environmental services
Evaluated n Procedures and Practicesn Facility design and Environment of Care Issuesn Patient Risk Factorsn Infection Ratesn Innovative Infection Prevention Products and
Practices
Spencer M, et al. A Multidisciplnary Team Working Toward Zero Infection Rate. Poster presented
AORN 2006; March 19-23, 2006; Washington DC. Spencer M., et al. A Multidisciplinary Team working toward Zero Orthopedic Infection Rate. Global
Infectious Disease Conference, Tufts Medical School, Boston, MA October 2009
Team Intent: Zero Healthcare-associated Infections
The teams: SSI, VAP, CLABSI, UTI, MRSA, C.difficile
Books: Power Versus Force – David Hawkins, MD 48 Laws of Power – Robert Greene
7
Issues Identified By Team
2003: The Operating Room:• Traffic control• Surgical attire• Operating room cleaning• Processing of instruments• Air handling system and laminar flow• Surgical hand scrub
2004: Surgical infection prevention (SIP) core measures• Silver postoperative dressings for Spine Service• CHG for central line care
2005: Antibacterial sutures – full year evaluation
2006-2007 MRSA and MSSA Eradication Program - 2 ½ year process CHG biopatch for central lines and Maximal Barrier Kits
2008• Chlorhexidine preop, intraop, postop • Clostridium difficile – room decontamination and bleach • V.A.P. checklist and prevention guidelines
2009-2010:• Post-op anitmicrobial dressings – all incisions covered• Central line checklist and patient education on prevention of HAIs
Operating Room - 2003
Re-training proper use of CHG/alcohol surgical scrub solution (6 hr residual activity)2006 changed to an 80%
alcohol based waterless hand scrub (6 hr residual activity also)
Distribution of 4 oz chlorhexidine (eg Hibiclens) in prescreening for all inpatient surgeries
9
Operating Room - 2003
Reviewed orderlies - room turnover procedures
Improved traffic control: new signage and monitoring system
Cloth cap use – if worn it must be covered when in room and total hair coverage monitored Hair harbors organisms Sweat in cloth caps? How often do they get
washed? Where are they stored? Would you eat a meal with
hair in it? Why then allow hair to potentially fall into surgical incisions?
Too many in this room, hair not adequately covered
Lab Coat Contamination
NEBH Lab coat study – cultured 6 coats in OR – 2 cultured Staph aureus (33%)
visibly soiled, pockets stuffed with books, food, scissors – even prescription pads!
Now offer fee for service cleaning physician lab coats in Environmental Services
Fellows/Residents/PA – provide weekly lab coats
Bacterial contamination of health care workers' white coats American Journal of Infection Control 37:(2) 101-105 (March 2009) 148 cultured: 23% Staph aureus, 18% MRSA
11
Peri-operative Environmental Evaluation
▫ Overall preventive maintenance schedule
▫ HVAC – filters and calibration of system, air quality & exchanges
▫ Laminar flow in all operating rooms (although data inconclusive that these
reduce SSI rates)▫ Terminal room cleaning procedures
on night shift – are there sufficient cleaning staff?
▫ Autoclave maintenance, instrument processing and sterilization
12
Complicated Orthopedic Instruments• Inspection of Orthopedic Instruments
▫ Lumens, grooves, sorting, hand cleaning, disassembly required – massive kits
▫ Many instruments cannot be disassembled
• Company contracted – disassemble and bead blast the material coagulated and hardened within lumens
• Instituted better pre-soaking and rinsing of tissue and blood from the instruments in the operating room before decontamination
• 2009 built new CSPD – state of the art
13
Environmental Upgrades
Upgraded all OR rooms to laminar flow
• (although data inconclusive that these reduce SSI rates)
• Annually - close the OR over the holidays - entire cleaning of the inner core and rooms
• Traffic Control – keep room doors closed and minimize traffic
14
Operating Room - 2004
• More frequent environmental safety rounds by team
• Infection control education forOR staff and surgeons
• Implement SCIP core measures: warming patient• surgical prophylaxis• hair clippers• increased oxygen
15
• Established a weekly cross-check system of patients identified with resistant organisms (MRSA/VRE)
• Weekly email from Infection Control to:• Pre-surgical Holding Unit• OR Surgical Scheduling• Patient Access (admitting)• Operating Room • Pre-assessment screening Unit (PASU)• PACU
• Master list of MRSA/VRE positive patients accessed on-line as a “live” file
Infection Control - 2005
16
FY05 Operating Room• Ultrasonic scrub
• movable carts, tables, poles and equipment
• 1500 pieces cleaned• OR, radiology, nursing
units
• Cost: ~$20,000• Done annually
• APIC 2005 - Poster• M Spencer: The E=MC2 Project: Environment =
Maintaining Cleanliness: A Multidisciplinary Approach To Establish a Routine Cleaning Schedule for Medical Equipment. APIC 2005 Baltimore Conference
17
Environmental Disinfection Developed cleaning
schedules for departments in Patient Care Services
Eliminated dirty buckets of water – instituted micro fiber mop per OR room and wash/dry onsite
Daily check sheet for terminal cleaning of OR at night and for all precaution cases
18
Environmental DisinfectionSilver Disinfectant Spray
that kills organisms up to 24 hrs on surfaces (Spectrum clene24 - (previously Agion)
Use in high volume areas that are cleaned once a day Radiology, Ambulatory Care Unit PACU and Pre-surgery Unit
Cubicle-curtain change policy –after each precaution discharge and 6 months on nursing unit 3 months - ICU and Ambulatory
Care
APIC 2007 – Poster Presentation: M Spencer: “Microbiologic Evaluation of a Silver Antimicrobial Disinfectant Spray” APIC San Jose, June 2007
Environmental Disinfection Assigning of staff to clean
before each use: Blood pressure cuffs Pulse oximeters Thermometers Leg tourniquets Bar Coding equipment Computers on Wheels
SHEA poster March 2009 – San Diego Conference
Spencer M, et al: Nondisposable Blood Pressure Cuffs as a Potential Source for Cross Contamination.
Patient Risk Factors
21
Prosthetic Joint InfectionRisk Factors
• Obesity • Diabetics and pre-diabetics• Poor patient hygiene • Revision surgery• Malignancy• Steroid Use• Rheumatoid Arthritis• Chronic Renal Insufficiency• Malnutrition• Blood Transfusion• Prior Infection in joint
• Berbari E. et al: Clinical Infectious Diseases 1998;27:1247–54
22
MRSA and Staph aureus Eradication Program
Prescreening ProcessTopical Decolonization ProtocolVancomycin for MRSA
Kim D, Spencer M, Davidson S, et al. J Bone Joint Surg Am. 2010;92:1820-6
23
February 2006 Obtained Anonymous Nares Cultures To Prove to Administration They Come In With Staph aureus
and MRSA
N = 133 patients
Purpose: to determine pre-opMRSA and Staph aureusColonization rates
Results:38 – Staph aureus (29%)
*5 - MRSA ( 4%)*all undiagnosed, no precautions used in OR or postop nursing unit, all MRSA cases received Cefazolin for prophylaxis
24
Implemented Decolonization Protocol
•5-day application of intranasal 2% mupirocin - applied twice daily - for MRSA and Staph aureus positive patients
•Prescription called in by Nurse Practitioner in prescreening unit
•Daily body wash with chlorhexidine (purchased by patient)
•MRSA Patients – Unique sticker system to notify Pre-surgery Unit of Vancomycin surgical prophylaxis
25
AORN Journal –Nov 2008 Vol 88, Nov. pages 818-820
“Dealing with Antibiotic Resistant Organisms”
AORN
Contact Precautions in Pre-op area, OR & PACU Gowns and gloves throughout procedure (in addition to
Mask already worn) by Circulator ad Anesthesia Circulator removes gown and gloves before leaving OR
to retrieve supplies/equipment Enhanced environmental cleaning after precaution cases
– therefore last case in room or scheduled last case of day
Use outside runner or circulator if possible to prevent contamination of perioperative environment MRSA – survives from 22-90 days on polyethylene Enterococci – 11 days Clostridium difficile – five months
28
MRSA/MSSA Eradication Results
From July 17, 2006 through July 2010
25,025 patients screened 5770 (23%) positive for Staph aureus 1027 ( 4%) positive for MRSA
Repeat nasal screens on MRSA patients revealed 78% eradication
29
Time Period Inpatient surgeries # Surgical Infections % MRSA/MSSA
FY06 10/01/05-07/16/06* 5293* 24* 0.45%*
FY0707/17/06-09/30/07 7019 6 0.08%
FY08 10/01/07-09/30/08 6323 7 0.11%
FY09 10/01/08-09/30/09 6364 11 0.17%
FY10 10/01/10-07/31/10 5397 5 0.09%
*historical controls
% MRSA and Staph aureus SSI
30
Time Period Inpatient surgeries # MRSA SSI MRSA % #Infections/#MRSA+
FY06 10/01/05-07/16/06 5293* 10 (NA) 0.19% NA
FY0707/17/06-09/30/07 7019 3 (3+) 0.04% 3/ 309 (0.97%)
FY08 10/01/07-09/30/08 6245 4 (2+) 0.06% 2/242 (0.83%)
FY09 10/01/08-09/30/09 6366 6* (2+) 0.09% 2/234 (0.85%)
FY10 10/01/10-07/31/10 5397 0 0.00% 0/208 (0%)
*isolates have been sent for pulse field gel electrophoresis
5 of the 6 isolates were available for PFGE and were not related genetically
% MRSA SSI in
MRSA + Screened Patients
31
Time Period Inpatient surgeries # MSSA SSI MSSA % #MSSA Infections/# MSSA +
Historical controlsFY06
10/01/05-07/16/06 5293* 14 (NA) 0.26% NA
Screened PatientsFY0707/17/06-09/30/07 7019 3 (3+) 0.04% 3/1588 (0.19%)
FY08 10/01/07-09/30/08 6245 3 (1+) 0.05% 1/ 1422 (0.07%)
FY09 10/01/08-08/31/09 6364 5 (3+) 0.08% 3/1403 (0.21%)
FY10 10/01/10-07/31/10 5397 5 (4+) 0.07% 4/1232 (0.32%)
% Staph aureus (MSSA) SSI in
Screen + Patients
FDA Cleared “Innovative Technologies"
Antiseptic cloth 2% chlorhexidine gluconate (CHG) impregnated
Urologic devices - Foley catheters-hydrogel/silver, Ureteral stents-triclosan eluting, Implantable prostheses—antibiotic
Central venous catheters - CHG-impregnated disk (dressing), Silver alone, Silver sulfanilamide (SS), SS/CHG, Minocycline/rifampin
Peritoneal catheters Silver-coated Vascular catheters Silver/antibiotic-coated Orthopedic devices external fixation pins- Silver Antibiotic-
impregnated polymethylmethacrylate (PMM) Surgical sutures - Braided and monofilament with triclosan Topical Skin Adhesives - proven microbial barriers
Product Format CHG Concentration Healthcare Uses
Topical solution SpongeapplicatorsSwab sticksAmpules
2% or 3.15% With 70% isopropyl alcohol
Skin preparation for surgery, invasive procedures, central lines to prevent SSI and BSI
Scrub solution Liquid detergent (sudsing base)
2% or 4% aqueous Preoperative showering/bathing General skin cleansing
Washcloth Impregnated single-use washcloth/wipe
2% aqueous Daily bathing in ICU patients
Dental solution Oral rinse 0.12% Decontaminate oral cavity (ventilator-associated pneumonia prevention protocols)
Gauze dressing Cotton-weave gauze dressing
0.5% with paraffin Wounds or burns
Catheter dressing CHG pad or integrated with semi-permeable transparent dressing
2% gel pad or foam disk Peripherally inserted central catheters Central line dressings
Hand rub Waterless antiseptic hand gel
1% alcohol based with emollients
Hand sanitizer for healthcare personnel (nonsoiled hands)
Sample of Chlorhexidine Products for Healthcare Use
BSI = bloodstream infection; CHG = chlorhexidine gluconate; ICU = intensive care unit; SSI = surgical site infection
New CHG Irrigation Solution
Wound Debridement and Cleansing system ▫ CHG concentration is 0.05%, lowest FDA-
cleared concentration of this antiseptic▫ Testing shows that this concentration kills and
inhibits Staphylococcus, CA-MRSA, HA-MRSA, Coagulase negative Staphylococcus, Pseudomonas aeruginosa, E. Coli and Aspergillus niger
▫ IrriSept passed the FDA-required safety testing for irritation, immune response and cytoxicity.
▫ There are only three limitations to use: (1) it should not be used on the eyes; (2) near the ear canal; or (3) on individuals sensitive to CHG.
35
Antisepsis with Chlorhexidine
2% CHG/70% alcohol skin preparation (tinted orange) Has a lasting effect on the skin
~ 2 days postop Iodophors are fast kill but no long
term effect CHG dry time is 3 minutes (to
prevent fires)
• Evidence that chlorhexidine/ alcohol achieves better skin antisepsis than iodophor
Darouiche et al NEJM 2010 Ostrander et al JBJS Am 2005 Saltzman et al JBJS Am 2009
OR Air Current Contamination
In teaching hospitals:
Surgeon leaves roomResident, Physician Assistant or Nurse Practitioner work on incisionCirculating Nurse counts sponges and starts room breakdownScrub Technician starts breaking down tables and preparing instruments for Central ProcessingAnesthesia move in and out of roomInstrument representative might leave roomVisitors may leave room
Suture with Staphylococcus colonies
Air settling plates in the operating room at the last hour of a total joint case
Potential for Contamination of Sutures at End of Case
39
NEBH
Antibacterial Suture Staph aureus Culture Plate Study
• A pure culture - 0.5 MacFarland Broth - of Staph aureus was prepared on a plate
• A coated antibacterial suture was aseptically cut and planted and incubated for 24 hrs
• Photo #1 shows zone of inhibition at day 5
• Photo # 2 shows zone of inhibition at day 10
• Plate on right is a non-coated suture. Staph aureus growth right over it
5 day zone of inhibition
10 day zone of inhibition
40
2005 – New England Baptist HospitalOne Year Prospective Study of
3800 Total Joints and Antimicrobial Sutures
• In July, 2005 – implemented use of antibacterial sutures for a full year evaluation – changed product over July 4th holiday and did not tell all surgeons (only those involved with study)
At the end of the year long trial period:▫ 45% reduction in surgical site
infections caused by Staph aureusand MRSA
▫ Reduction in total joint infections rate during trial period 0.44% - 0.33%
NAON Poster Presentation - 2010 • Spencer M, et al: Reducing the Risk of Orthopedic Infections: The Role of
Innovative Suture Technology
IRGACARE® MP (triclosan) Properties
IRGACARE MP 2,4,4′-tri-chloro-2′-
hydroxydiphenyl ether High-purity material that
meets USP specifications for triclosan, with minimal residue content
IRGACARE MP is safe Biocompatible, nontoxic Consumer products
Mouthwash, toothpaste, soaps, cosmetics
IRGACARE MP is effective Active against methicillin-
sensitive and methicillin-resistant S aureus and S epidermidis (most common for device infections)
Active against Escherichia coli and Klebsiella pneumoniae
IRGACARE MP is compatible with suture processing Maintains excellent suture
properties
41
USP=United States Pharmacopeia.
Zurita R et al. Macromol Biosci. 2006;6:58-69.
Ming Xet al. Surg Infect (Larchmt). 2007;8:201-207.
Ming X et al. Surg Infect (Larchmt). 2008;9:451-457.
Barbolt TA. Surg Infect (Larchmt). 2002;3(suppl 1):S45-S53.
Compared with controls, IRGACARE MP-coated polyglactin 910 sutures produced
• Substantial zones of inhibition (all sizes; P<.05)1
• Zones of inhibition against methicillin-sensitive and methicillin-resistant S aureus and S epidermidis1
• Microbial recovery of gram-positive and gram-negative organisms was significantly lower with IRGACARE MP-coated sutures vs non-coated sutures (P<.01)2
• Effective antiseptic activity of IRGACARE MP was present for at least 96 hours2
IRGACARE MP-Coated Sutures: In Vitro Activity
1Rothenburger S, et al. Surg Infect (Larchmt). 2002;3(suppl 1):S79-S87.2Edmiston CE, et al. J Am Coll Surg. 2006;203:481-489.
Suture without IRGACARE MP
Suture with IRGACARE MP
IRGACARE® MP (triclosan): Mode of Action
Chlorinated phenolic biocide—a “phenol” with multi-targeted biocidal mechanisms Nonspecific effects on cell
membrane activities and cell membrane integrity
Blocks active site of the enoyl-acyl carrier protein reductase—an essential enzyme in fatty acid synthesis—building cellular components and reproduction
43
Why IRGACARE® MP (triclosan)?
Able to withstand the manufacturing process
Cost-effective Safe in tissues Performance/function
properties Handling Absorption profile, breaking-
strength retention
44
IRGACARE® MP (triclosan): Pharmacokinetics
Well absorbed Well distributed in the body Rapidly metabolized in liver to the
glucuronide/sulfate conjugate T½=10 to 13 hours
Excreted through kidneys
45
IRGACARE® MP (triclosan) and Microbial Resistance
IRGACARE MP is very effective against S aureus, S epidermidis and E coli, which are the 3 most important bacteria related to SSIs
There is no connection between the use of IRGACARE MP and significant antibiotic resistance
The use of IRGACARE MP may lead to the overall reduction of the antibiotic burden Decreases the risk of SSIs and the resulting
application of stronger antibiotics against SSIs The use of IRGACARE MP is not associated with
increased bacterial virulence that raises the antibiotic burden
46
Ming X et al. Surg Infect (Larchmt). 2007;8:209-213.
Barbolt TA. Surg Infect (Larchmt). 2002;3(suppl 1):S45-S53.
Ford HR et al. Surg Infect (Larchmt). 2005;6:313-321.
Articles Related To Antibacterial Sutures
*Justinger, C, et al. Antibiotic coating of abdominal closure sutures and wound infection. Surgery 2009;145:330-4. (*RCT)
Rothenburger S, et al. In vitro antimicrobial evaluation of Coated VICRYL* Plus Antibacterial Suture (coated polyglactin 910 with triclosan) using zone of inhibition assays. Surg Infect 2002;3 Suppl 1:S79-87
Ford HR, et al. Intraoperative handling and wound healing: controlled clinical trial comparing coated VICRYL plus antibacterial suture (coated polyglactin 910 suture with triclosan) with coated VICRYL suture (coated polyglactin 910 suture). Surgical Infections. 6(3):313-21, 2005.
Edmiston CE, et al. Bacterial adherence to surgical sutures: can antibacterial-coated sutures reduce the risk of microbial contamination? Journal of the American College of Surgeons. 203(4):481-9, 2006 Oct .
Protect OR Staff: ETHIGUARD* Blunt Point Needles
ETHIGUARD Blunt Point Needles provide blunt point geometry that allows soft tissue penetration with minimum force, designed to decrease the incidence of needlestick injuries.
ETHICON offers 97 codes on ETHIGUARD Blunt Point needles, combined with braided and monofilament suture materials including Coated VICRYL* Plus Antibacterial Suture, MONOCRYL* Plus Antibacterial Suture, and PDS* Plus Antibacterial Suture, etc.
ETHIGUARD Needles are available on the most frequent use needles for fascia closure.
The sutures combined with ETHIGUARD needle have size from 1 to 3-0.
ETHIGUARD needle with a ribbed and flattened body affords greater stability in the needle holder, for improved protection against slipping and for precise control.
ETHIGUARD Blunt Point Needles require no changes to surgical technique.
ETHIGUARD Blunt Point Needles are supplied in secured needle packaging.
TPB-1: 65 mm
SHB: 26 mm
CTB-1: 36 mm
CTXB: 48 mm
CTB-2: 26 mm
CTB: 40 mm
* Trademark
INCISIONAL SKIN ADHESIVE TO PREVENT EXOGENOUS CONTAMINATION TO INCISION
DURIN G POST-OP PERIOD
Skin Issues in Orthopedics
Anterior fusion with tape burns
Posterior fusion with contaminated steri-strips
Contaminated steri-strips
We Do Not Recommend Incisions opened to air with contaminated steristrips
Bacteria feed off blood (and sugar)
Incisions are in exudative stage of wound healing first few post-op days
Sent home on day 3- 4 with incision and underlying tissues starting proliferative stage of wound healing
Wounds are susceptible to dehiscence
52
Obesity and Surgical Incision Incision collects fluid –
serum, blood - growth medium for organisms
Spine fusions -incisions close to the buttocks or neck
Heavy perspiration common
Body fluid contamination from bedpans/commodes
Friction and sliding - skin tears and blisters
Itchy skin - due to pain medications - skin breakdown
Octyl-Cyanoacrylate Topical Skin AdhesiveCyanoacrylates were developed in 1949
1970s - n-butyl-2-cyanoacrylate
1999 - 2-Octyl-Cyanoacrylate (DERMABOND) 1st FDA approved Topical Skin Adhesive
Today – over 5 million patients a year are treated with Incisional Adhesive
• 2 Octyl cyanoacrylate has the longest carbon side chain for increased flexibility and, increased breaking strength versus butyl cyanoacrylate1
• In vivo and In vitro studies demonstrate a proven microbial barrier against bacteria which may cause infection.
• 24 months shelf life, stores at room temperature
• a violet, non tattooing dye for easy observation
1. Quinn, JV Tissue Adhesives in Wound Care, BC Decker 1998. Attached are chapters from the book.
Mechanism of action
Combination of monomer and
plasticizers, that polymerizes to form a
flexible/pliable adhesive film
Sets or cures within 45-90 seconds
following final layer and reaches full
mechanical strength in 2.5 minutes
If needed, can be wiped from skin within
10 seconds after application or with a
petroleum based product after setting
Adhesive film sloughs or falls off wound
within 7-10 days as skin re-epithelializes
Equivalent to 7 days wound healing
strength in 3 minutes1
OCA: 300-500 microns thick compared to other N- Butyls at :
<50 microns thick
1. Singer and Hollander, Lacerations in Acute Wounds: An evidence-based guide, p.85
Benefits for surgeons, nurses, patients, and hospitalsPhysician, Hospital -centered Benefits
Proven microbial barrier for lasting protection
7 days of wound healing strength in 3 minutes for strong closure and peace of mind
No time spent removing staples or sutures
Reduces needle stick exposure
Increases patient satisfaction
Reduced Hospitalization Costs
Nurse, Patient -centered Benefits
• Reduces number of suture set ups
• Ease of Post Op wound checks
• Reduces number of wound dressings
• Shower immediately
• Excellent Cosmesis
Incisional Adhesive on Total Knee Incision
Incisionial Adhesive and AMD Dressing
Knee: Sealed with Dermabond, covered with antimicrobial Telfa and a transparent dressing
Hip: Sealed with Dermabond, covered with antimicrobial gauze and transparent dressing
Healed incision
If Incisional Adhesive is Not used: Antimicrobial Post-op Dressings
Antimicrobial (AMD) gauze forall post-op incisions that are not sealed with adhesive
Impregnated with a 0.2% PHMB(Polyhexamethylene Biguanides)
Initial dressing and subsequent dressings done by nursing staff
At day of discharge – dressingleft in place for an additional 48 hrs postop
No More Flimsy Post-op Dressings ABD with Paper or Gauze Tape
Check your residents and physician assistants sterile technique
•ABD pads may be stuffed in lab coat pockets during rounds
•Gloves may not be worn for dressing changes.
•Lack of hand hygiene
•Bandage scissors often used between patients with no disinfection between use
•Often discard bloody dressings in regular waste rather than get red bag and bring to dirty utility room – they rush early AM rounds to get into OR
2008 Standardization: Antimicrobial Dressing
(AMD) By Nursing Staff
AMD secured with MeFix tape for protection from exogenous contamination and prevention of tape burn
Allow skin/incision to create proper temperature beneath dressing to enhance wound healing
Protect the incision from exogenous contamination until discharge
Protect the incision from trauma
Incision protected until discharge and then 48 hrs post-op
Knee Dressings with Ace
Ace bandage one day post-op with blood strikethrough after drain removed – nurses told to “reinforce” – another reason to have antimicrobial gauze beneath the ace bandage.
Initial post-op dressing is usually an ace wrap for compression.
AMD gauze are in post-op dressing kits to offer protection to the incision in first two days
Spine Service and Shoulders
AMD sealed with Tegaderm left on until discharge
AMD Island dressing – left on until discharge
Rotator cuff (and total shoulders) – Dermabond is being used or an AMD gauze covered by tegaderm – left on until discharge
Practices with LimitedSupporting Data
64
Surgical Incise Drapes
Iodophor impregnated incise barrier drape (“sacred cow”)
Cost: >~ $60,000/year Surgeon preference based on adhesion to skin
and theoretical reduction in skin organisms
beneath the drape during surgery
A search on MEDLINE http://www.ncbi.nlm.nih.gov/entrez/query.fcgi
brought up 10 studies on antimicrobial drapes for human use. All but two were published in the 1980’s.
Of the 10 studies concerning drapes impregnated with a disinfectant, results were mixed. Other studies pointed out that, even though the survival rate of bacteria may have been reduced by using antimicrobial drapes, it represented little or no difference in wound infection rates when compared to conventional preparations
65
Bacitracin/Polymixin Irrigation
Feb 2007 - stopped routine use of Bacitracin/Polymixin Irrigation
Cost: > $110,000/year No evidence reduces SSI Cases of anaphylactic shock associated
with Bacitracin Approved limited use for revisions, long
spine cases, allografts and infected cases (irrigation and debridements)
1. Topical irrigation with polymyxin and bacitracin for spinal surgery. Surgical Neurology [Surg Neurol] 1998 Sep; Vol. 50 (3), pp. 208-12.
2. Intraoperative anaphylactic shock after bacitracin irrigation. Anesthesia And Analgesia [Anesth Analg] 1990 Oct; Vol. 71 (4), pp. 430-3.
66
UTI PreventionGoal: Prevent bladder infection that would lead to seeding of prosthetic device upon catheter removal
Closed catheter systems Silver-coated latex /silicone Prevent UTIs postoperatively Ideally in for no more than 48 hrs Some old literature that supports silver catheters
We use silver latex catheters - no longer use Bactrim prophylaxis post-op (unless re-catheterized for urinary retention)
New SCIP core measure – catheters removed within 48 hrs
Our Experience and Evidence
OR Cleanup
Bundle Approach to Reducing SSI
NEBH SSI Rates 2003 – 2010(outpatient and inpatient infections)
69
GENERAL SSI FY03 FY04 FY05 FY06 FY07 FY08 FY09 FY10(Oct-Jul)
# Infections 6 1 3 4 2 2 1 0# Procedures 1073 920 780 692 567 467 369Infection Rate 0.6 0.1 0.4 0.5 0.3 0.3 0.2 0
ORTHOPEDIC SSI# Infections 63 60 49 46 39 37 28 27# Procedures 8837 9669 9216 8986 9027 8884 8890 8256Overall Infection Rate 0.7 0.6 0.5 0.5 0.4 0.4 0.3 0.3#Hip Infections 14 5 4 7 5 5 10 8 Hip Prosthesis Rate 1.0 0.3 0.2 0.4 0.3 0.3 0.5 0.4#Knee Infections 21 14 11 7 7 11 9 7 Knee Prosthesis Rate 1.6 1.0 0.7 0.4 0.3 0.5 0.4 0.3#Laminectomy Infec. 6 9 7 7 12 4 0 3 Laminectomy Rate 0.7 0.9 0.6 0.8 1.3 0.5 0.0 0.6#Spinal Fusions Infec. 5 15 12 12 5 5 3 3 Spinal Fusion Rate 0.8 2.0 1.4 1.1 0.4 0.4 0.3 0.4
70
Creative and Fun Hand Hygiene Educational Programs
Infection Control - $7000.00/year budget
Most Important Control Measure
HAND HYGIENE – wash off the dirt!
Wash hands several times a day – especially if you have had gloves on for more than 20 minutes – organisms multiply every 20 minutes and communicate efficiently with one another to transfer antibiotic resistance factors
Alcohol Foam, Liquid and Hand Wipes
All patients receive package of alcohol wipes in admission kit – encourage them to sanitize hands
Foam or liquid sanitizer In each patient room, outside rooms, cafeteria and other areas
Wash hands often – before eating, before leaving work, after contamination
73
Got Soap? - Engage Your Staff!!
Engaged the OR staff in a Got Soap? Campaign OR Nurses Surgeons Administration Infection
Control
74
November 2005 “Partners in Hand Hygiene”
January 2006“Let it S.N.O.W.”Stop Nosocomial Organisms by Washing
April 2006“Do the H.O.P.”Hand washing Offers Protection
Patient and Visitor Empowerment
Routine Cafeteria Displays
75
LUAU
Let Us Always Use
Good Hand Hygiene Cafeteria Cruise Ship Alcohol hand rub to
enter cafeteria Posters – Engage
the Staff Hawaiian music and
food Raffle table and
candy distributed
Be Creative – Make it Fun
76
Creative and Interactive
Glo-Germ “Bug Beat” Fair Contact
Plates
77
16 poster displays: Admitting Surgical Services Micro Lab EVS, Transport Nursing Units
M.R.S.A . Fair – Program
Make Resistance Stay Away
78
2007
79
2007
80
2008
82
Hand Hygiene Observations
0
10
20
30
40
50
60
70
80
90
100
2nd Qtr 3rd Qtr 4th Qtr 1st Qtr 2nd Qtr 3rd Qtr 4th Qtr
Overall Direct Care Providers Hand Hygiene Compliance FY08-09
Before After`
0
10
20
30
40
50
60
70
80
90
2nd Qtr FY08 3rd Qtr 4th Qtr 1st Qtr FY09 2nd Qtr 3rd Qtr 4th Qtr
Physician and Hospitalist Hand Hygiene Compliance FY08-09
Before After
0
10
20
30
40
50
60
70
80
90
100
2nd Qtr 3rd Qtr 4th Qtr 1st Qtr 2nd Qtr 3rd Qtr 4th Qtr
RN Hand Hygiene Compliance FY08-09
Before After`
83
Tools for Success
• Senior leadership and Board of Trustees involvement – “lead the effort” from top down
• Structured program with clearly defined goal of zero tolerance for HAIs
• Communication – effective and consistent
• Ongoing and creative education
• Financial support to Infection Control program
Thank YouThank You